NO974566L - Peptider og terapeutisk middel for autoimmune sykdommer som inneholder disse - Google Patents

Peptider og terapeutisk middel for autoimmune sykdommer som inneholder disse

Info

Publication number
NO974566L
NO974566L NO974566A NO974566A NO974566L NO 974566 L NO974566 L NO 974566L NO 974566 A NO974566 A NO 974566A NO 974566 A NO974566 A NO 974566A NO 974566 L NO974566 L NO 974566L
Authority
NO
Norway
Prior art keywords
amino acid
side chain
independently represents
autoimmune diseases
acid residue
Prior art date
Application number
NO974566A
Other languages
English (en)
Norwegian (no)
Other versions
NO974566D0 (no
Inventor
Nobuyuki Yamagata
Kenji Ogata
Masako Wagatsuma
Hitoshi Takanashi
Original Assignee
Hoechst Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Japan filed Critical Hoechst Japan
Publication of NO974566D0 publication Critical patent/NO974566D0/no
Publication of NO974566L publication Critical patent/NO974566L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Transplantation (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
NO974566A 1995-04-07 1997-10-02 Peptider og terapeutisk middel for autoimmune sykdommer som inneholder disse NO974566L (no)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP11759295 1995-04-07
JP7344649A JPH08333390A (ja) 1995-04-07 1995-11-24 ペプチド及びそれからなる自己免疫疾患治療剤
PCT/JP1996/000917 WO1996031529A1 (fr) 1995-04-07 1996-04-03 Peptides et medicaments contre les maladies auto-immunes contenant ces peptides

Publications (2)

Publication Number Publication Date
NO974566D0 NO974566D0 (no) 1997-10-02
NO974566L true NO974566L (no) 1997-11-26

Family

ID=26455689

Family Applications (1)

Application Number Title Priority Date Filing Date
NO974566A NO974566L (no) 1995-04-07 1997-10-02 Peptider og terapeutisk middel for autoimmune sykdommer som inneholder disse

Country Status (13)

Country Link
EP (1) EP0821003B1 (de)
JP (1) JPH08333390A (de)
KR (1) KR19980703610A (de)
CN (1) CN1183784A (de)
AT (1) ATE247664T1 (de)
AU (1) AU704656B2 (de)
CA (1) CA2217679C (de)
DE (1) DE69629559T2 (de)
ES (1) ES2203685T3 (de)
HU (1) HUP9801680A3 (de)
NO (1) NO974566L (de)
NZ (1) NZ304437A (de)
WO (1) WO1996031529A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6858210B1 (en) 1998-06-09 2005-02-22 La Jolla Pharmaceutical Co. Therapeutic and diagnostic domain 1 β2GPI polypeptides and methods of using same
IL125262A0 (en) 1998-07-07 1999-03-12 Yeda Res & Dev Synthetic peptides and pharmaceutical compositions comprising them
US6913749B2 (en) 1998-11-02 2005-07-05 Resistentia Pharmaceuticals Ab Immunogenic polypeptides for inducing anti-self IgE responses
US6935730B2 (en) 2000-04-03 2005-08-30 Unicorn Image Products Co. Ltd. Of Zhuhai One-way valve, valve unit assembly, and ink cartridge using the same
WO2003096966A2 (en) 2002-05-21 2003-11-27 Resistentia Pharmaceuticals Ab Chimeric ige polypeptides and host cells
CN1169829C (zh) 2002-06-27 2004-10-06 北京大学人民医院 非t细胞结合肽及其用途
CA2571710A1 (en) 2004-06-24 2006-11-02 Nicholas Valiante Small molecule immunopotentiators and assays for their detection
JP7000161B2 (ja) 2015-05-26 2022-01-19 ジェムバックス アンド カエル カンパニー，リミティド 新規ペプチド及びこれを含む組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2072356A1 (en) * 1989-12-29 1991-06-30 James L. Urban Diagnosis and treatment of diseases
DE69232871T2 (de) * 1991-06-24 2003-05-08 Chiron Corp Polypeptide des hepatitis c-virus (hiv)
WO1993006135A1 (en) * 1991-09-23 1993-04-01 Genentech, Inc. Diagnosing and treating autoimmune disorders
EP0666867A4 (de) * 1992-09-14 1997-08-27 Brigham & Womens Hospital Reagentien und methoden zur behandlung rheumatoischer arthritis.

Also Published As

Publication number Publication date
WO1996031529A1 (fr) 1996-10-10
CA2217679C (en) 2008-03-25
CA2217679A1 (en) 1996-10-10
JPH08333390A (ja) 1996-12-17
KR19980703610A (ko) 1998-12-05
ES2203685T3 (es) 2004-04-16
DE69629559D1 (de) 2003-09-25
HUP9801680A3 (en) 1999-06-28
AU704656B2 (en) 1999-04-29
EP0821003A1 (de) 1998-01-28
HUP9801680A2 (hu) 1998-11-30
MX9707662A (es) 1997-11-29
EP0821003B1 (de) 2003-08-20
DE69629559T2 (de) 2004-06-17
EP0821003A4 (de) 2000-05-24
CN1183784A (zh) 1998-06-03
NZ304437A (en) 1999-01-28
ATE247664T1 (de) 2003-09-15
AU5162296A (en) 1996-10-23
NO974566D0 (no) 1997-10-02

Similar Documents

Publication Publication Date Title
Yang et al. Sugar-assisted ligation in glycoprotein synthesis
AU758843B2 (en) Compounds of unstable dipeptidyl peptidase IV inhibitors
DK0750506T3 (da) Bredspektrede, antimikrobielle forbindelser og fremgangsmåder til anvendelse af disse
DE68916932T2 (de) Antimikrobielle peptide, zusammensetzungen, die diese enthalten, und verwendungen daraus.
AU4837300A (en) Antimicrobial theta defensins and methods of using same
Pote et al. Otoconin-22, the major protein of aragonitic frog otoconia, is a homolog of phospholipase A2
NO974566L (no) Peptider og terapeutisk middel for autoimmune sykdommer som inneholder disse
Gross α, β-Unsaturated and related amino acids in peptides and proteins
AU6020099A (en) Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein
Karlsson Chemistry of some potent animal toxins
ES2081817T3 (es) Polipeptido con secuencias principales repetidas que se fijan en la celula.
MY147920A (en) Antibacterial and antiviral peptides from actinomadura namibiensis
US5681821A (en) Fluorescent 1-peptidylaminoalkanephosphonate derivatives
WO1997002287A1 (en) Parevins and tachytegrins
US6307016B1 (en) Parevins and tachytegrins
Ogishima et al. Partial amino acid sequences of two mitochondrial and two microsomal cytochrome P-450's from adrenal cortex
ATE83242T1 (de) Cysteinreiche, gamma-glutaminsaeure und betaalanin-einheitenaufweisende peptide, verfahren zu deren herstellung und ihre verwendung.
US20180072775A1 (en) Beta-Hairpin Peptidomimetics
Gaudron et al. NAcSDKP analogues resistant to angiotensin-converting enzyme
WO1998004584A1 (en) Cyclic decapeptide antibiotics
WO2006108686A3 (en) Bnp agonists
US6790829B1 (en) Cyclic decapeptide antibiotics
RU94004998A (ru) Хризоспермины, способ их получения, лекарственное средство на их основе и штамм apiocrea chrysosperma
AU7858794A (en) Novel derivatives of peptides therapeutically active in the cascade sequence for blood coagulation, process for their preparation and pharmaceutical compositions containing same
USRE38828E1 (en) Parevins and tachytegrins

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application